Anavex Life Sciences Corp (AVXL)

[neiu]

I have no idea what is going on with this post. Mike is showing that Veronica Francardo, PhD will be presenting a poster at this year's MJFF Parkinson's Disease Therapeutics Conference this Oct. 30.

The grant was given to Nilsson, which really goes to the lab she oversees at Lund.

http://www.lunduniversity.lu.se/lucat/group/v1000356

Francardo most likely specializes in this type of research so Nilsson co-authors the paper with her as per the poster at the World Parkinson Congress 2016.

http://www.anavex.com/investigating-the-potential-neurorestorative-effects-of-a-clinical-sigma-1-receptor-agonist-in-a-mouse-model-of-parkinsons-disease/

Francardo is the lead author of the poster with Nilsson part of it as well and it shows that research was supported by the MJFF. And yes, MJFF is a partner with the World Parkinson Coalition that organizes that conference so I don't believe that Francardo will be presenting the exact same piece she did then.

These two have co-authored many papers over the years as well so I don't accept your assertion that because Francardo is presenting that it has nothing to do with MJFF grant given to Anavex and Nilsson.

http://portal.research.lu.se/portal/en/persons/veronica-francardo(9c206658-28b7-4a7c-a4e3-2f199ca7618a)/publications.html

I'm still waiting for your rebuttal as to IND's don't include trial design BTW.